![Simon Tate](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Simon Tate
Direttore/Membro del Consiglio presso ELIEM THERAPEUTICS, INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Simon Tate
Società | Posizione | Inizio | Fine |
---|---|---|---|
ELIEM THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/02/2019 | - |
Independent Dir/Board Member | 01/02/2019 | - | |
INTERMEDIATE CAPITAL GROUP PLC | Corporate Officer/Principal | 01/01/2021 | - |
Storia della carriera di Simon Tate
Precedenti posizioni note di Simon Tate
Società | Posizione | Inizio | Fine |
---|---|---|---|
Bridge Valley Ventures LLP
![]() Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge. | Investitore di Private Equity | 01/12/2017 | 01/01/2021 |
Convergence Pharmaceuticals Ltd.
![]() Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 06/10/2010 | 12/04/2018 |
Direttore Tecnico/Scientifico/R&S | 06/10/2010 | 12/04/2018 | |
Fondatore | - | 12/04/2018 | |
Calchan Ltd.
![]() Calchan Ltd. BiotechnologyHealth Technology Calchan Ltd. operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain. The company was founded by Brenda Elizabeth Reynolds in 2011 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
BIOGEN INC. | Corporate Officer/Principal | - | - |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - | - |
Calchan Holdings Ltd.
![]() Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Calchan Holdings Ltd. develops novel oral state-dependent calcium channel modulators for chronic pain. The company was founded on February 25, 2011 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Formazione di Simon Tate
University Of Dundee | Graduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 7 |
Stati Uniti | 3 |
Canada | 2 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 7 |
Finance | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
BIOGEN INC. | Health Technology |
ELIEM THERAPEUTICS, INC. | Health Technology |
INTERMEDIATE CAPITAL GROUP PLC | Finance |
Aziende private | 5 |
---|---|
Convergence Pharmaceuticals Ltd.
![]() Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Calchan Holdings Ltd.
![]() Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Calchan Holdings Ltd. develops novel oral state-dependent calcium channel modulators for chronic pain. The company was founded on February 25, 2011 and is headquartered in London, the United Kingdom. | Health Technology |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Calchan Ltd.
![]() Calchan Ltd. BiotechnologyHealth Technology Calchan Ltd. operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain. The company was founded by Brenda Elizabeth Reynolds in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
Bridge Valley Ventures LLP
![]() Bridge Valley Ventures LLP Investment ManagersFinance Bridge Valley Ventures LLP is a Venture Capital firm founded in 2017. Bridge Valley Ventures LLP is headquartered in Cambridge. | Finance |
- Borsa valori
- Insiders
- Simon Tate
- Esperienza